Two novel acharan sulfate lyases (ASL1 and ASL2: no EC
number) have been purified from Bacteroides stercoris HJ-15 which was isolated from human intestinal bacteria with glycosaminoglycan (GAG) degrading enzymes. These enzymes were purified to apparent homogeneity by a com-
bination of QAE-cellulose, DEAE-cellulose, carboxy-
methyl±Sephadex C-50, hydroxyapatite and HiTrap SP Sephadex C-25 column chromatography with the final
specific activity of 50.5 and 76.7 mmol´min21´mg21,
respectively. Both acharan sulfate lyases are single subunits
of 83 kDa by SDS/PAGE and gel filtration. ASL1 showed
optimal activity at pH 7.2 and 45 8C. ASL1 activity was
inhibited by Cu21, Ni21 and Co21, but ASL2 activity was
inhibited by Cu21, Ni21and Pb2. Both enzymes were
slightly inhibited by some agents that modify histidine and
cysteine residues, but activated by reducing agents such as dl-dithiothreitol and 2-mercaptoethanol. Both purified
bacteroidal acharan sulfate lyases acted to the greatest
extent on acharan sulfate, and to a lesser extents on heparan
sulfate and heparin. They did not act on de-O-sulfated
acharan sulfate. These findings suggest that the biochemical
properties of these purified acharan sulfate lyases are
different from those of the previously purified heparin
lyases, but these enzymes belong to heparinase II.
Keywords: Bacteroides stercoris HJ-15; acharan sulfate lyase; heparinase; acharan sulfate; purification.
Acharan sulfate, a glycosaminoglycan (GAG) isolated from
the giant African snail Achatina fulica, has a structure
closely related to heparin and heparan sulfate with a
uniform repeating disaccharide structure of !4)-a-d-
GlcNAc (1!4)-a-l-IdoA2S(1! where GlcN is glucosa-
mine and IdoA is iduronic acid [1]. Heparin and heparan
sulfate GAGs are comprised of alternating 1!4 linked
glucosamine and uronic acid residues. Heparan sulfate is composed primarily of monosulfated disaccharides of N-acetyl-d-glucosamine and d-glucuronic acid while heparin is composed mainly of trisulfated disaccharides of N-sulfonyl-d-glucosamine and l-iduronic acid [2,3].
Related to degradation of these GAGs, some heparin lyases that can eliminatively cleave polysaccharides, heparin or heparan sulfate GAGs have been reported [4±6]. These enzymes are classified as: (a) heparin lyase I
(heparinase I, EC 4.2.2.7), acting primarily at the !4)-a-
d-GlcNS(6S or OH)(1!4)-a-l-IdoA2S(1! linkages pre-
sent in heparin; (b) heparin lyase II (heparinase II or
Correspondence to D.-H. Kim, College of Pharmacy, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-ku, Seoul 130-701, South Korea. Fax: 1 82 2 957 5030, Tel.: 1 82 2 961 0374, E-mail: dhkim@khu.ac.kr
Abbreviations: DUA, 4-deoxy-a-l-threo-hex-4-enopyranosyl uronic acid; IdoA, iduronic acid; GlcA, glucuronic acid; GlcN, glucosamine; GAG, glycosaminoglycan; CM, carboxymethyl; IEF, isoelectric
focusing; TLCK, N-a-tosyl-l-lysylchloromethane; TPCK, N-a-tosyl-l-phenylalanylchloromethane.
(Received 2 January 2001, revised 12 March 2001, accepted 12 March
2001)
heparitinase II), acting at the !4)-a-d-GlcNS(6S or
OH)(1!4)-a-l-IdoA(2S or OH) or -b-d-GlcA(1! linkages
present in both heparin and heparan sulfate, where GlcA is
glucuronic acid; and (c) heparin lyase III (heparinase III or
heparitinase, EC 4.2.2.8), acting on the !4)-a-d-GlcNS(or
Ac)(1!4)-b-d-GlcA(or IdoA)(1! linkages found exclu-
sively in heparan sulfate. The heparin lyases have become
increasingly important in understanding the biological roles
and structure of the GAGs (and proteoglycan), which are
involved in the well-known anticoagulant activity [7] and
the regulation of various cellular processes such as the
potentiation of angiogenesis [8] and the modulation of
cellular proliferation [9]. Several heparin lyases of bacterial
origin have been purified and characterized from various
species including Flavobacterium heparinum [4,10], Bacil-
lus sp. BH 100 [11], Prevotella heparinolyticus (formerly
known as Bacteroides heparinolyticus) [12], and Bacter-
oides stercoris HJ-15 [13]. B. stercoris HJ-15 has been
recently isolated from human intestine and it contains
several kinds of GAG degrading enzymes including
heparin, heparan sulfate, acharan sulfate and chondroitin
sulfate [13].
Recently, we purified a novel heparin lyase, which is close
to Flavobacterial heparin lyase III, from this B. stercoris
HJ-15 [14]. The previously purified enzyme from Bacter-
oides stercoris HJ-15 cleaved heparin as well as heparan
sulfate, although heparin lyase III from Flavobacterium
heparinum was highly specific for heparan sulfate. However,
this B. stercoris HJ-15 potently cleaved acharan sulfate as
well as heparin compared to Flavobacterium heparinum.
Therefore, we tried to purified acharan sulfate lyases
from B. stercoris HJ-15 that acts predominantly on acharan
sulfate.
2636 B.-T. Kim et al. (Eur. J. Biochem. 268)
MATERIALS AND METHODS
Materials
Acharan sulfate was prepared as described by Kim et al. [1]. Heparin (porcine intestinal mucosa), heparan sulfate (porcine intestinal mucosa) chondroitin sulfate A (bovine trachea), chondroitin sufate B (porcine intestinal mucosa), chondroitin sufate C (shark cartilage), thioglycolic acid
(sodium salt), QAE cellulose Fastflow, and HA Ultrogel
(microcrystalline hydroxyapatite, 4% beaded in agarose)
were supplied by Sigma Chemical Co. SDS, carboxymethyl
(CM)±Sephadex C-50, SP±Sephadex C-25, Sephacryl
S-300 HR resins and molecular mass markers for gel
filtration and protein electrophoresis were obtained from Pharmacia Biotech Co (Uppsala, Sweden). DEAE-cellulose resin was purchased from Wako Pure Chemical Industries (Tokyo, Japan). Protein assay kit and Coomassie Brilliant Blue R-250 were from Bio-Rad (Hercules, CA, USA). Tryptic soy broth was provided by Difco Co. All other chemicals were of the highest grade available.
Bacterial strains and purification of two acharan sulfate lyases
B. stercoris HJ-15 was isolated and cultivated as described previously [14]. It was cultured anaerobically under an
atmosphere of 90% nitrogen and 10% carbon dioxide at 378C in 100 L of tryptic soy broth (pH 7.2) containing heparin (0.15 g´L21) instead of glucose, 0.01 w/v% sodium thioglycolate and 0.1 w/v% ascorbic acid. The cultured cells were harvested in the late exponential phase (11±12 h) by centrifugation at 4000 g for 30 min at 4 8C and the
resulting cell pellet was washed twice with NaCl/Pi. The cell pellet was suspended in 600 mL of 50 mm sodium phosphate buffer, pH 7.0. The cell suspension (30 mL at a time) was placed into a 50-mL centrifuge tube and
disrupted by 30-min periods of sonication at 1-s intervals
on an ultrasonic processor (Eyela Co., Tokyo, Japan) at
80% output with cooling. Cell debris was removed by
centrifugation at 25 000 g for 60 min at 4 8C. All operations
were performed at 4 8C unless otherwise noted. The cell
extract (600 mL) was passed through a QAE-cellulose
column (5 40 cm) which had been pre-equilibrated with
50 mm sodium phosphate buffer, pH 7.0. The column was
washed with the same buffer until no acharan sulfate lyase
activity was detectable in the effluent. The fractions which
passed through the column were applied to a DEAE-
cellulose column (5 30 cm) equilibrated with 50 mm
sodium phosphate buffer, pH 7.0. The column was then
eluted with the same buffer until any acharan sulfate lyase
activity could not be detected. The noninteracting fluid
passed through the column was collected. The total volume
of the flow through was 1800 mL. The eluate was loaded
onto a CM±Sephadex C-50 column (3 30 cm) pre-
viously equilibrated with 50 mm sodium phosphate buffer, pH 7.0. The column was washed with 1 L of the same buffer and then eluted with a 2-L linear gradient of KCl of 0±0.6 m in 50 mm sodium phosphate buffer, pH 7.0 at a flow rate of 105 mL´h21. All fractions obtained were
assayed for heparin lyase and acharan sulfate lyase
activities. Three fractions (Fr-a, Fr-b and Fr-c) containing
q FEBS 2001
the activity of these enzymes were collected separately and assayed for the activities degrading acharan sulfate and heparan sulfate. Fr-a, exhibiting acharan sulfate lyase activity, was dialyzed against 50 mm sodium phosphate
buffer, pH 7.0 for the further purification. The dialyzed
enzyme preparation (330 mL) was applied to a HA Ultrogel
column (2.5 10 cm) equilibrated with 50 mm sodium
phosphate buffer, pH 7.0. After being washed with 500 mL of the same buffer, the column was eluted with an 800-mL linear gradient, of 50±400 mm sodium phosphate buffer
(pH 7.0) at a flow rate of 120 mL´h21. The active fractions
were pooled and dialyzed twice against 2 L of 50 mm
sodium phosphate buffer, pH 7.0. The dialyzed enzyme
(165 mL) was loaded onto a SP±Sephadex C-25 column
(3 30 cm) equilibrated with 50 mm sodium phosphate
buffer, pH 7.0. After washing the unadsorbed proteins with 800 mL of the same buffer, an 800-mL linear KCl gradient (0±0.5 m) in 50 mm sodium phosphate buffer, pH 7.0 was performed to elute the acharan sulfate lyase at a flow rate of 75 mL´h21. Two active fractions (ASL1, fractions 91±99; ASL2, fractions 118±120) were investigated for homo-
geneity by SDS/PAGE.
Enzyme activity assays
The activities of GAG lyases, including acharan sulfate lyase, were measured according to the previously published procedure [14]. The activity was calculated from the
change of absorbance per min using an extinction coefficient of 3800 m21 for products [1 U ˆ 1 mmol of
4-deoxy-a-l-threo-hex-4-enopyranosyl uronic acid (DUA) containing product formed per min] [15]. The specific
activity was calculated by dividing the mmol product produced per min by mg protein in the cuvette. Protein concentration was measured by a Bradford assay using bovine serum albumin as a standard [16].
Characterization of acharan sulfate lyases
SDS/PAGE was performed for the determination of
molecular mass according to Laemmli's procedure [17].
The gels were stained with Coomassie Brilliant Blue R-250
solution and then further stained with silver. The pI value of
heparinase was determined by isoelectric focusing (IEF)
electrophoresis using Model 111 Mini IEF Cell (Bio-Rad)
according to the manufacturer's instructions. The molecular
mass of the native enzyme was estimated by gel-filtration
using Sephacryl S-300 HR column (1.6 70 cm) cali-
brated with gel filtration low molecular mass calibration
kit (from Sigma Co.) and high molecular calibration kit
(from Amersham Pharmacia Biotech). The pH optimum of
acharan sulfate lyases were determined using 50 mm
sodium phosphate buffer (pH 6.0±8.5). Temperature depen-
dency of the enzyme was investigated by measuring enzyme activity at different temperatures (25±60 8C). To investigate the effect of divalent metal ions and KCl on the lyase activity, divalent metal ion (final concentration,
100 mm), chemical modifying agents (50 mm) and KCl (0±500 mm) were added into the reaction mixture. Kinetic constants of acharan sulfate lyases were determined by measuring the initial rates at various substrate concentra-
tions (200, 400, 600, 1000, 2000 and 3000 mg) under the standard reaction conditions.
q FEBS 2001
The lyase activities on other sulfated polysaccharides
were also measured. One milligram of each substrate was
added to the reaction mixture. Because of their low
solubility, 100 mg of acharan sulfate, de-O-sulfated acharan
sulfate and N-sulfoacharan sulfate were used in this assay.
Amino-acid composition analysis was performed on an
Applied Biosystem model 420/130 Derivatizer/Amino-acid
Analyzer using phenyl isothiocyanate precolumn derivati-
zation chemistry. Hydrolysis was perfomed by using 6 m
hydrochloric acid/0.1% phenol at 155 8C for 1 h.
Internal amino-acid sequences of two purified acharan
sulfate lyases were analyzed on a Applied Biosystem
protein sequencer model 492.
RESULTS
Purification of acharan sulfate lyases
Bacteroides stercoris HJ-15, which degrades a variety of
GAGs including heparin, heparan sulfate and chondroitin
sulfates [13], constitutively produced acharan sulfate lyase
activity. However, when induced with acharan sulfate or
heparin, total acharan sulfate activity increased by about
3.5-fold (data not shown). Following ultrasonic disruption
of B. stercoris HJ-15, the crude extract was subjected to a
combination of QAE-cellulose and DEAE-cellulose column
chromatography to remove interacting proteins. Acharan
sulfate lyase activity passed through these columns without
binding to the matrices. The effluent was further purified to
Fig. 1. Elution profile of CM±Sephadex
C-50 ion exchange chromatography (A)
and SP Sephadex column chromatography
(B). Solid circle, acharan sulfate lyase
activity; open triangle, heparin lyase activity;
solid line only, absorbance at 280 nm.
New bacteroidal heparinase (Eur. J. Biochem. 268) 2637
homogeneity by a series of CM±Sephadex C-50 column chromatography (Fig. 1A), hydroxyapatite Ultrogel chro-
matography and finally SP±Sephadex C-25 column chro-
matography (Fig. 1B). The specific activity and total
activity at each purification step are summarized in
Table 1. The acharan sulfate lyase activity was divided
into two parts by SP±Sephadex C-25 chromatography. The
specific activity of the first eluted fraction (acharan sulfate
lyase 1) had 50.5 U´mg protein21 with a yield of 15.5%,
and that of the second eluted fraction (acharan sulfate lyase
2) was 76.7 U´mg protein21 with a yield of 11.6%. Both
acharan sulfate lyases were apparently homogeneous by
SDS/PAGE and their molecular masses were identically
estimated to be 83 000 Da, respectively (Fig. 2).
Characterization of two acharan sulfate lyases
The molecular masses of acharan sulfate lyase 1 and 2 under nondenaturing conditions were determined by gel filtration (Fig. 2). Both acharan sulfate lyase 1 and 2 were estimated to be about 83000 Da. It suggests that both
acharan sulfate lyase 1 and 2 are composed of one subunit. The optimal pHs of acharan sulfate lyases were determined to be 7.2±7.5 for both acharan sulfate and heparin. (Fig. 3) and the optimum temperature for the maximal activity was shown at 45 8C (Fig. 4).
Both acharan sulfate lyase 1 and 2 activities were slightly
increased by addition of Mg21 or Mn21, whereas they were
severely inhibited by Cu21 and Ni21 (Table 2). Particularly,
lunes, 30 de marzo de 2009
jueves, 8 de noviembre de 2007
Suscribirse a:
Entradas (Atom)